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Short-chain ketone production by engineered
polyketide synthases in Streptomyces albus
Satoshi Yuzawa 1,2,11, Mona Mirsiaghi1,3, Renee Jocic1, Tatsuya Fujii2,4, Fabrice Masson1,3,
Veronica T. Benites1,2, Edward E.K. Baidoo1,2, Eric Sundstrom1,3, Deepti Tanjore1,3, Todd R. Pray1,3,
Anthe George2,5, Ryan W. Davis5, John M. Gladden2,5, Blake A. Simmons 1,2, Leonard Katz2,6 &
Jay D. Keasling 1,2,6,7,8,9,10
Microbial production of fuels and commodity chemicals has been performed primarily using
natural or slightly modiﬁed enzymes, which inherently limits the types of molecules that can
be produced. Type I modular polyketide synthases (PKSs) are multi-domain enzymes that
can produce unique and diverse molecular structures by combining particular types of cat-
alytic domains in a speciﬁc order. This catalytic mechanism offers a wealth of engineering
opportunities. Here we report engineered microbes that produce various short-chain (C5–C7)
ketones using hybrid PKSs. Introduction of the genes into the chromosome of Streptomyces
albus enables it to produce >1 g · l−1 of C6 and C7 ethyl ketones and several hundred mg · l−1
of C5 and C6 methyl ketones from plant biomass hydrolysates. Engine tests indicate these
short-chain ketones can be added to gasoline as oxygenates to increase the octane of
gasoline. Together, it demonstrates the efﬁcient and renewable microbial production of
biogasolines by hybrid enzymes.
DOI: 10.1038/s41467-018-07040-0 OPEN
1 Biogical Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, United States. 2 Joint BioEnegy Institute,
Emeryville, California 94608, United States. 3 Advanced Biofuels & Bioproducts Process Development Unit, Lawrence Berkeley National Laboratory, Berkeley,
California 94720, United States. 4 Research Institute for Sustainable Chemistry, Institute for Synthetic Biology, National Institute of Advanced Industrial
Science and Technology, Higashi-hiroshima, Hiroshima 739-0046, Japan. 5 Department of Biomass Science and Conversion Technologies, Sandia National
Laboratory, Livermore, California 94551, United States. 6 QB3 Institute, University of California, Berkeley, California 94720, United States. 7 Department of
Bioengineering, University of California, Berkeley, California 94720, United States. 8 Department of Chemical and Biomolecular Engineering, University of
California, Berkeley, California 94720, United States. 9 Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Building 220,
Kemitorvet, DK-2800 Kgs, Lyngby, Denmark. 10 Center for Synthetic Biochemistry, Shenzhen Institutes for Advanced Technologies, Shenzhen, Guangdong
518055, China. 11Present address: Biotechnology Research Center, The University of Tokyo, Tokyo 113-8657, Japan. These authors contributed equally:
Satoshi Yuzawa, Mona Mirsiaghi. Correspondence and requests for materials should be addressed to S.Y. (email: usyuzawa@g.ecc.u-tokyo.ac.jp)
or to J.D.K. (email: jdkeasling@lbl.gov)
NATURE COMMUNICATIONS |          (2018) 9:4569 | DOI: 10.1038/s41467-018-07040-0 | www.nature.com/naturecommunications 1
12
34
56
78
9
0
()
:,;
According to the United States (US) Environmental Pro-tection Agency (EPA), global carbon emissions from fossilfuels have increased by >500% since 1950 and reached
approximately 10 billion tonnes in 2014 (https://www.epa.gov/
ghgemissions/global-greenhouse-gas-emissions-data). The trans-
portation sector contributed about 15% of greenhouse gas (GHG)
emissions, with 95% of that coming from petroleum-based fuels.
The US industrial sector also contributed approximately 20% of
GHG emission from the burning of fossil fuels for energy and the
production of commodity chemicals from fossil resources. Fuels
and commodity chemicals produced from renewable sources,
such as biomass, would signiﬁcantly reduce GHG emissions.
A US National Bioeconomy Blueprint released by the White
House proposed to reduce our dependence on petroleum through
biological generation of fuels and chemicals1. Microbial fermen-
tation is an attractive approach to produce these compounds
renewably. For example, several genetically engineered microbes
have been developed to produce fatty acid esters, fatty alcohols,
and fatty ketones that could be used as drop-in replacements for
diesel fuels or as ﬂavors and fragrances2–6. Compared to the
traditional biofuel ethanol, higher alcohols offer advantages as
gasoline alternatives due to their higher energy density and lower
hygroscopicity. Microbial production of C3–C10 alcohols has also
been reported in several genetically engineered microbes7–10.
Hydrocarbons, such as alkanes or alkenes, are of particular
interest because they are similar to the petroleum-based fuels
currently in use (a mixture of C4–C12 hydrocarbons) and have
higher energy content than ethanol. Bio-based production of
hydrocarbons has also been reported11–13.
Short-chain ketones could potentially be used as gasoline
replacements or oxygenates in gasoline because of their high
octane numbers14. However, although some microbes (mainly
Clostridium strains) naturally produce acetone, no natural
metabolic pathway is known to produce detectable levels of the
other short-chain ketones. Recently, E. coli was engineered with a
promiscuous β-keto-thiolase from R. eutropha, a coenzyme A
(CoA) transferase from Clostridium acetobutylicum, and an
acetoacetate decarboxylase from C. acetobutylicum, and produced
1.3 g · l−1 of butanone and 240 mg · l−1 of 2-pentanone from the
corresponding acyl-CoAs15,16. Although this CoA dependent
chain elongation pathway, which resembles the reversed β-
oxidation pathway, is one of the promising routes to produce
methyl ketones, it is not known if the β-keto-thiolase can utilize
branched-chain acyl-CoAs to produce other types of methyl
ketones or produce ethyl ketones using propionyl-CoA in chain
elongation.
Previously, we engineered E. coli to produce low titers
(<5 mg · l−1) of an ethyl ketone (3-pentanone) or a methyl
ketone (butanone) by introducing a hybrid polyketide synthase
(PKS)17–19. The ethyl ketone-producing PKS was constructed by
fusing LipPks1, a PKS subunit of lipomycin synthase from
Streptomyces aureofaciens Tü117 (hereafter referred to S. aur-
eofaciens) and a thioesterase (TE) domain of the erythromycin
PKS from Saccharopolyspora erythraea, and by inactivating the
ketoreductase (KR) domain of LipPks1. The methyl ketone PKS
was created by further engineering the ethyl ketone PKS where
the second acyltransferase (AT) domain of LipPks1 that incor-
porates methylmalonyl-CoA was replaced with an AT homologue
that incorporates malonyl-CoA (Fig. 1). These engineered
enzymes were capable of producing small amounts of ﬁve ethyl
ketones and ﬁve methyl ketones by condensing different acyl-
CoAs and carboxyacyl-CoAs in vitro17. To construct a more
efﬁcient PKS, we further engineered the ketone PKSs and intro-
duced the genes into several Streptomyces species. Together, these
developments enabled production of industrially relevant ketones
at greater than 1 g · l−1 in shake ﬂasks. These results suggest
potential industrial applicability of these microbial platforms to
produce short-chain ketones that could be used as a gasoline
replacement and/or a gasoline additive.
Results
Rational PKS engineering. Recently, we found that the
employment of an alternative translational start site (TSS) in
LipPks1 dramatically increased the protein level of LipPks1+ TE
and the corresponding product levels, 3-hydroxy acids, in a
heterologous Streptomyces host, Streptomyces venezuelae ATCC
10712 (hereafter referred to S. venezuelae), compared to the
originally annotated start codon20. Using the newly identiﬁed
TSS, which truncates a part of the N-terminal tail of LipPks1, we
redesigned the ketone PKS genes (Fig. 1). In addition, we sought
to change the inactivating mutation of the KR domain from the
serine to the catalytic tyrosine since the role of the serine could be
partially replaced by the other amino acids based on the
mechanisms shown in Supplementary Fig. 1a. We therefore
mutated the codon that encodes the tyrosine to that of pheny-
lalanine (SSIAGVWGSGDHGAYA to SSIAGVWGSGDH-
GAFA). The resulting ethyl and methyl ketone PKS genes (Fig. 1
and Supplementary Data 1) were introduced into the chromo-
some of four Streptomycetes, and short-chain ketone-production
levels were determined as discussed below.
Streptomyces host selection. Natural products from the genus
Streptomyces have been the source for many clinically useful
pharmaceuticals. In fact, over one-third of known polyketides and
nonribosomal peptides originate from this genus21. Successful
heterologous production of natural products of Streptomyces
origin has mostly been achieved in well-characterized model
Streptomyces hosts such as S. coelicolor, S. lividans, and S. albus22.
To compare different Streptomyces strains for short-chain ketone
production, we selected S. coelicolor A3(2) (hereafter referred to S.
coelicolor, a close relative of S. lividans) and S. albus J1074
(hereafter referred to S. albus) for experimentation. S. venezuelae
was also examined because the parental PKS gene (LipPks1+ TE)
was well-expressed in this host after optimizing the TSS as
mentioned above. In addition, since the majority of the ethyl and
methyl ketone-generating PKSs originates from LipPks1, S. aur-
eofaciens was also included in the experiments described below.
To investigate the impact of using different Streptomyces hosts
for short-chain ketone production, we constructed actinophage
ΦC31 attP/int vectors carrying an apramycin resistance gene and
the genes for mCherry (negative control), N-terminal tail-
truncated ethyl ketone PKS, or N-terminal tail-truncated methyl
ketone PKS, which can be efﬁciently transferred from E. coli
ET12567/pUZ8002 into various Streptomyces23. These genes were
placed under control of the gapdh promoter from Eggerthella
lenta (Pgapdh(EL)) that was shown to work in S. coelicolor and S.
venezuelae at similar strength (Supplementary Table 1)24. The
introduced vector is site-speciﬁcally integrated into the Strepto-
myces chromosomes that carry a cognate attB site by site-speciﬁc
recombination with attP mediated by the integrase encoded in
each vector. Apramycin resistant transconjugants were isolated
and examined. Correct integration of each construct was veriﬁed
by the polymerase chain reaction (PCR) using primers listed in
Supplementary Table 2 (see also Supplementary Fig. 2 and
Supplementary Table 3). Each strain was named by the plasmid
used (Supplementary Table 4).
Each of the 12 recombinant strains was initially grown in TSB
for 2–4 days and then inoculated into shake ﬂasks containing 30
ml of medium 042 (M042). M042 was developed to maximize
production of various secondary metabolites by Streptomyces25
and gave the best titers among several different media tested
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(Supplementary Fig. 3 and Supplementary Table 5). Each ﬂask
was ﬁtted with a silicon sponge closure, which permits exchange
of gasses but reduces evaporation of water and short-chain
ketones compared to normal ﬂask caps. After culturing for ﬁve
days at 30 °C, the culture broth was mixed with an equal volume
of methanol and incubated at 50 °C overnight to fully convert 3-
keto acids produced by PKSs to the corresponding ketones
(Supplementary Fig. 4). After ﬁltration, crude extracts were
analyzed by liquid chromatography time-of-ﬂight mass spectro-
metry (LC-TOF-MS). As shown in Fig. 2a, all of the strains
transformed with the gene encoding the ethyl ketone PKS
produced expected 2-methyl-3-pentanone and 4-methyl-3-hex-
anone, which has never been produced biologically. Among them,
S. albus produced the highest amounts of the ketones (106 ± 6
mg · l−1 of 2-methyl-3-pentanone and 39 ± 3mg · l−1 of 4-
methyl-3-hexanone). We also tested a S. albus strain that
encodes N-terminal tail-truncated ethyl ketone PKS that harbors
S to A mutation in the KR domain. As expected, the S-to-A
mutant produced lower amounts of ketones compared to the Y-
to-F mutant (Supplementary Fig. 1b). For methyl ketones
(Fig. 2b), S. albus was the only strain that produced expected 3-
methyl-2-butanone (18 ± 6 mg · l−1) and 3-methyl-2-pentanone
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Fig. 1 Hybrid polyketide synthases engineered to produce short-chain ketones. Short-chain ketone-producing polyketide synthases (PKSs) were created by
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(3 ± 1 mg · l−1). Microbial production of the two methyl ketones
has not been reported previously. However, the lower titers of
methyl ketones were not expected because AT-swapped LipPks1
+ TE produced 3-hydroxyhexanoic acid from n-butyryl-CoA and
malonyl-CoA with an approximately tenfold faster kcat compared
to 2-methyl-3-hydroxyhexanoic acid production from n-butyryl-
CoA and methylmalonyl-CoA by LipPks1+ TE17. In fact, the S.
albus strain that harbors the AT-swapped LipPks1+ TE
produced 42 ± 1 mg · l−1 of 2-methyl-3-hydroxypentanoic acid,
whereas the S. albus strain harboring the original LipPks1+ TE
produced 8.8-fold less 2,4-dimethyl-3-hydroxypentanoic acid
(Supplementary Fig. 5c). Shorter ketones, in theory, evaporate
faster, which, in part, may explain lower methyl ketone titers
observed.
S. albus engineering. To improve ketone production levels in S.
albus, we tested different constitutive promoters to drive
expression of the hybrid PKS genes (Supplementary Table 1). We
employed the ermE* promoter (PermE*), the best characterized
promoter used in many Streptomyces strains26, or the recently
developed kasO* promoter (PkasO*), which showed approximately
50% stronger activity in S. coelicolor and S. venezuelae than
Pgapdh(EL)24,27. The newly constructed S. albus strains produced
lower amounts of ethyl ketones and methyl ketones compared to
the corresponding Pgapdh(EL) strains (Fig. 2c,d and Supplementary
Table 4). Although we could detect similar levels of short-chain
ketones from strains that encode PKS genes under the kasO*
promoter, it appears that the strength of ermE* promoter is very
low in S. albus.
We previously developed Streptomyces integration vectors that
encode actinophage VWB attP/int or BT1 attP/int, which can be
used to insert DNA into speciﬁc chromosomal locations of a target
genome23. Although the frequency of obtaining transconjugants of
S. albus with a vector containing BT1 attP/int was very low,
reasonable numbers of transconjugants were observed using the
VWB attP/int system. Using this system, we constructed S. albus
strains with a gene that encodes an N-terminal tail-truncated ethyl
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Fig. 2 Short-chain ketone production in engineered Streptomyces strains. Unless otherwise noted, each strain was cultured in Medium 042 (M042) for
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ketone PKS or methyl ketone PKS under control of Pgapdh(EL)
(Supplementary Table 4). As shown in Fig. 2e, the ethyl ketone
production levels were lower than those produced by the
corresponding ΦC31 strains. However, the methyl ketone produc-
tion was slightly higher (Fig. 2f). Although the amount of 3-methyl-
2-butanone was similar (18 ± 6mg · l−1 vs. 16 ± 2mg · l−1), ca.
fourfold higher production was observed for 3-methyl-2-pentanone.
Short-chain ketone production from plant biomass. We selec-
ted ALB188 and ALB191 to examine short-chain ketone pro-
duction from plant biomass. These two strains gave the highest
titers of ethyl and methyl ketones in M042. M042 contains glu-
cose (1%), glycerol (1%), and corn starch (1%) as major carbon
sources. We replaced these carbon sources with corn stover
alkaline hydrolysates, which contain glucose and xylose at
approximately 7:3 molar ratio. We prepared modiﬁed M042
(MM042) using the plant biomass hydrolyate, resulting in ﬁnal
concentrations of glucose and xylose at 6.5% and 2.2%, respec-
tively (Supplementary Table 5).
Although it took approximately 9 days to consume all of the
carbon in the MM042 (Supplementary Fig. 6), as shown in
Fig. 2g, h (see also Supplementary Figs 7–9), 466 ± 54 mg · l−1 of
2-methyl-3-pentanone and 289 ± 21 mg · l−1 of 4-methyl-3-
hexanone were produced by ALB188 (755 ± 75 mg · l−1 in total),
and 52 ± 1 mg · l−1 of 3-methyl-2-butanone and 65 ± 3 mg · l−1 of
3-methyl-2-pentanone were produced by ALB191
(116 ± 4 mg · l−1 in total). The cell density of each culture was
estimated by the Bradford assay (Fig. 2i), and these data suggest
that the increased levels of short-chain ketones were mainly
achieved by the increased amounts of cell mass generated in
media containing plant biomass.
We also tested if we could change the product ratios by
changing intracellular concentrations of acyl-CoA substrates. To
do this, we supplemented MM042 with valine, isoleucine, or
threonine. These amino acids could potentially be converted to
isobutyryl-CoA, 2-methylbutyryl-CoA, and propionyl-CoA,
respectively, by endogenous enzymes. Propionyl-CoA could be
further converted to methylmalonyl-CoA. As expected, when
valine was added to the medium, levels of short-chain ketones
produced from isobutyryl-CoA (2-methyl-3-pentanone and 3-
methyl-2-butanone) increased signiﬁcantly, whereas higher titers
of 4-methyl-3-hexanone and 3-methyl-2-pentanone were observed
when isoleucine was added into the medium (Fig. 2g, h).
Short-chain ketone production levels were not dramatically
affected in the medium containing threonine. When all of the
three amino acids were added to the medium, the highest level of
ethyl ketone production was observed (758 ± 35mg · l−1 of 2-
methyl-3-pentanone and 329 ± 13mg · l−1 of 4-methyl-3-hexa-
none, 1087 ± 47mg · l−1 in total, Fig. 2g) with ~4% of maximum
theoretical yield. For methyl ketones, the medium containing
isoleucine gave the best titer (99 ± 6mg · l−1 of 3-methyl-2-
butanone and 143 ± 3mg · l−1 of 3-methyl-2-pentanone, 242 ±
3mg · l−1 in total, Fig. 2h) with ~1% of maximum theoretical yield.
These feeding experiments demonstrate that short-chain ketone
production can be controlled by addition of amino acids to the
growth medium, although using a strain that overproduces target
amino acids would be favorable in an industrial application to
reduce fermentation cost. While the kinetic parameters of
LipPks1+ TE indicate that other short-chain ketones such as
butanone and 4-methyl-2-pentanone could also be produced
in vivo from the corresponding starter substrates, propionyl-CoA
and isovaleryl-CoA28, it would be necessary to eliminate produc-
tion of isobutyryl-CoA and 2-methylbutyryl-CoA, substrates for
which the AT has lower Km values than for propionyl-CoA and
isovaleryl-CoA29.
We also tested whether we could produce short-chain ketones
in a bioreactor. Signiﬁcant evaporation of target ketones
prevented the use of the system, however (Supplementary Fig. 10).
The reason is still unclear but one possible reason is that higher
mass transfer of oxygen in the bioreactor results in more rapid
conversion of sugars to 3-keto acids, which could be converted to
the corresponding ketones at a faster rate because of more intense
aeration and agitation. These conditions would also accelerate
stripping of ketones from the fermentation broth, resulting in
more rapidly decreasing titers once the ketone removal rate
exceeds the production rate.
The use of organic solvent overlay has been shown to be a
successful method for accumulating volatile products produced
by microbial cultures30. To overcome the evaporation issue
during fermentation, we selected decane and dodecane as overlays
and tested the efﬁcacy by growing ALB188 in medium 042 in the
presence of those organic solvents. Unfortunately, we observed
lower amounts of ketones. According to the cell density
measurements, decane and dodecane may be toxic to S. albus
(Supplementary Fig. 11).
Short-chain ketones as gasoline oxygenates. Ethanol is a
renewable oxygenate added to gasoline. Unless it is used in a ﬂex-
fuel vehicle, no more than 15% ethanol can be added to the
gasoline due to EPA regulation. Because there are few ﬂex-fuel
vehicles in the US, there is a limited amount of ethanol needed,
which the US has more than enough capacity to produce. Having
oxygenates that can be blended into gasoline at greater than 15%
would allow more renewable substitutes in gasoline and would
lower GHG emissions.
The methyl and ethyl ketones we biologically produced could
potentially be used as gasoline replacements or oxygenates in
gasoline. Research octane number (RON) and Motor octane
number (MON) of eight different short-chain ketones have been
reported14. Importantly, our engineered PKSs can produce six of
them (butanone, 2-pentanone, 3-pentanone, 3-methyl-2-buta-
none, 3-hexanone, and 4-methyl-2-pentanone). Butanone,
2-pentanone, 2,4-dimethyl-3-pentanone, and cyclopentanone
were blended into a model gasoline surrogate, which suggested
their ability to increase the RON and MON14. Here, we further
expanded the analysis by blending ten different short-chain
ketones (C3–C7) into an actual gasoline, CARBOB, at 10, 20, and
30 Vol%. CARBOB is a special Reformulated Blendstock for
Oxygenate Blending formulae mandated by the state of California
(E10 gasoline=CARBOB+ Ethanol at 10 Vol%). Our analysis
indicates that all short-chain ketones tested, including ketones
produced by our engineered S. albus strains, increase RON and
MON of CARBOB (Fig. 3a, b). Furthermore, most of them
behaved better than 1-butanol, a well-known biofuel, although
none of them exceeded the performance of ethanol in terms of
octane number. However, as shown in Supplementary Table 6,
2-methyl-3-pentanone and 3-methyl-2-butanone have very simi-
lar fuel properties as isooctane (octane numbers, energy density,
boiling point, melting point, and ﬂash point), and outperform
ethanol in terms of energy density, auto ignition temperature, and
water solubility. 4-Methyl-3-hexanone and 3-methyl-2-pentanone
(which were also produced from the S. albus strains) were not
included in the blending study because they were either not
commercially available or too expensive for the test.
Discussion
Microbial production of fuels and commodity chemicals has been
performed primarily using natural enzymes, which inherently
limits the types of molecules that can be produced. Engineering
natural enzymes (single to a few amino acid mutations) has been
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shown to be effective in broadening the substrate or product
range or changing the enzyme kinetics, but generally the titers of
the engineered enzymes are signiﬁcantly reduced relative to the
natural enzymes; to our knowledge, the highest titer reported for
biogasoline production (e.g. short-chain alkanes or alcohols) was
728 mg · l−1 when using these mutated enzymes9,11,31,32. Type I
modular PKSs have the potential to produce a very broad range of
molecules by combining multiple, simple individual steps (cata-
lyzed by protein domains) in an understandable way. By isolating
and characterizing each step and reconstituting them in various
combinations, these systems have been shown to produce com-
plex chemical structures not observed in nature. Unfortunately,
engineered PKSs generally have signiﬁcantly reduced kinetics
compared to their wild-type counterparts and, as a result, pro-
duce low titers of the desired product. In the present work, we
demonstrated efﬁcient production of potential fuels using a
hybrid PKS at a titer exceeding 1 g · l−1. It should be noted that
actual ketone production titers should be higher because 3-keto
acids are chemically unstable and gradually converted into the
corresponding ketones during fermentation (Supplementary
Fig. 4b), which evaporate from cultures at very fast rates (Sup-
plementary Fig. 11a). To our knowledge, this is the highest titer of
products generated with any engineered PKSs and the ﬁrst report
of engineered PKSs used to produce biogasolines. The short-chain
ketones produced by the engineered PKS could also be used as
solvents, ﬂavors, and fragrances. In addition, our ketone PKSs
produced the expected products with no observable off-target
products. As shown in Supplementary Figs 7–9, we observed
expected ketone products only (no peak shoulders and split
peaks). These non-natural hybrid enzymes were created by
physically combining different parts of wild-type PKSs using a
previously developed and recently reported PKS engineering
strategy to replace the native extension AT with a non-native AT
with highly conserved amino acid sequences, GTNAHVILE and
LPTY(A/P)FQ(H/R)xRYWL17. These domain boundaries are
very well conserved in type I modular PKSs33. Interestingly, very
similar sequences can also be found in type I iterative PKSs,
which could also be used to change substrate speciﬁcity without
disturbing protein quaternary structures. We also employed an
alternative TSS for LipPks1 to redesign ketone PKSs. Gene-
ﬁnding tools perform well in low GC content genomes but are
much less accurate for high GC genomes such as Streptomyces
genomes34. In fact, we found a TSS that greatly outperforms the
originally annotated start codon in heterologous expression of
LipPks120. Because most bioactive PKS products originate from
Strepromyces, more accurate gene-ﬁnding tools would facilitate
heterologous expression of the PKSs. We further demonstrated
that organisms engineered with these PKSs could utilize cellulosic
biomass to produce the target molecules. Together, our work
suggests that precisely engineered PKSs could be used to produce
a broad range of hydrocarbons that we currently derive from
fossil resources plus many molecules that we could never produce
from fossil resources in an efﬁcient manner from renewable
carbon sources.
Methods
Chemicals. All chemicals were purchased from Sigma-Aldrich (United States)
unless otherwise described.
Plasmids and strains. Plasmids and strains used in this study are listed in Sup-
plementary Table 4. The plasmids and strains have been deposited in the public
version of JBEI registry (http://public-registry.jbei.org) and are physically available
from the corresponding author upon request.
Plasmid construction. Brieﬂy, recognition sequence of SpeI was added to Strep-
tomyces integration vector (apramycinR, VWB)23 using primers listed in Supple-
mentary Table 7 to replace the integrase with SphI and SpeI and the promoter with
SpeI and NdeI (Supplementary Table 7). Using these sites, p21 was constructed.
p33 was constructed from p21 by replacing the mCherry gene with a PKS gene
from pSY07417 using NdeI and EcoRI. Similarly, P37 was constructed using a PKS
gene generated with NdeI and EcoRI from pSY07517. pSY172 encodes N-terminal
tail-truncated LipPks1+ TE20. The PKS gene was cut with NdeI and EcoRI and
inserted into p21 (pre-pSY186). To inactivate the KR domain, the KpnI-NheI
fragment from pSY087 that contains LipPks1 AT-KR-ACP tri-domain, in which
the catalytic serine in the KR was mutated to alanine17, was used to replace the
corresponding region in pre-pSY186 to construct pSY186. The KpnI-NheI frag-
ment from pSY074 was subcloned into a smaller vector, and the catalytic tyrosine
in the KR was mutated to phenylalanine by site-directed mutagenesis using primers
listed in Supplementary Table 7. The KpnI-NheI fragment was used to replace the
corresponding region in pSY186 to construct pSY188. The NdeI-EcoRI fragment
from pSY188 was used to construct all of the other plasmids that harbor the gene
encoding the ethyl ketone PKS. Similarly, the KpnI-NheI fragment from pSY075
was subcloned into a smaller vector and the catalytic tyrosine in the KR was
mutated to phenylalanine by site-directed mutagenesis using the same primers. The
KpnI-NheI fragment was used to replace the corresponding region in pSY188 to
construct pSY189. NdeI-EcoRI fragment from pSY189 was used to construct all of
the other plasmids that encode methyl ketone PKS (see also Supplementary
Fig. 12).
Conjugal transfer of vectors to Streptomyces. Conjugal transfer of integration
vectors to Streptomyces hosts was conducted using the method described in
Practical Streptomyces Genetics with slight modiﬁcations35. E. coli ET12567/
pUZ8002 was transformed with a desired plasmid employing selection on LB agar
containing apramycin (50 mg · l−1). A single colony was inoculated into 5 ml of LB
containing kanamycin (25 mg · l−1), chloramphenicol (15 mg · l−1), and apramycin
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Fig. 3 Octane numbers of short-chain ketones blended into a model
gasoline. Three ethyl ketones (green), ﬁve methyl ketones (blue), other
ketones (yellow), ethanol (gray square), and 1-butanol (gray circle) were
added into CARBOB at 10, 20, and 30 Vol%. a, b Research octane numbers
(a) and Motor octane numbers (b) were measured by ASTM methods
D2699 and D2700, respectively. Short-chain ketones produced by
engineered S. albus strains were shown as a dashed line. 2-methyl-3-
pentanone (green circle), 3-hexanone (green triangle), 3-pentanone (green
square), 4-methyl-2-pentanone (blue circle), acetone (blue triangle), 3-
methyl-2-butanone (blue square), 2-pentanone (blue diamond), butanone
(blue cross), cyclopentanone (yellow circle), 2,4-dimethyl-3-pentanone
(yellow square). CARBOB Reformulated Blend-stock for Oxygenate
Blending formula mandated by the state of California
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(25 mg · l−1) and grown at 37 °C. The overnight culture was used to seed 10 ml of
LB containing the same antibiotics (inoculum size was 5 Vol%), which was grown
at 37 °C to an OD600 of 0.4–0.6, which usually takes 4–6 h. The E. coli cells were
pelleted by centrifugation at 3000 × g for 5 min, washed twice with 10 ml of LB, and
resuspended in 1 ml of LB. Fresh Streptmyces spores were collected from a glycerol-
arginine plate23 (S. venezuelae) or Mannitol Soy (MS) agar plate (S. albus, S.
aureofaciens, and S. coelicolor) with 5 ml of 2x YT and incubated at 50 °C for 10
min. MS agar was prepared by adding 20 g of agar, 20 g of mannitol, and 20 g of
soybean ﬂour to 1 l of tap water and autoclaved. After autoclaving and cooling,
magnesium chloride was added at 10 mM. The spores (500 µl) and the E. coli cells
(500 µl) were mixed and brieﬂy spun down at 3000 × g for 2 min. Most of the
supernatant was poured off and spread on MS agar, and incubated at 23 °C (S.
venezuelae) or 30 °C (S. albus, S. aureofaciens, S. coelicolor) for 16–20 h. After
addition of 1 ml of water containing nalidixic acid (0.5 g · l−1) and apramycin (1.25
g · l−1), the plate was further incubated for 3–5 days to permit sporulation. A single
colony was inoculated into 3 mL of Tryptic Soy Broth (TSB) non-animal origin
(EMD Millipore, United States) containing nalidixic acid (25 mg · l−1) and apra-
mycin (25 mg · l−1). Following 2–4 days incubation at 30 °C, 100 µl of the culture
was spread onto glycerol-arginine agar (S. venezuelae) or MS agar (S. albus, S.
aureofaciens, and S. coelicolor). The plate was incubated for 4–7 days at 30 °C.
Spores were collected from the plate by adding 5 mL of water. The spore sus-
pension was ﬁltered using a syringe containing a piece of cotton wool. The
resulting suspension was mixed with equal volume of glycerol.
Genomic PCR. Gene integration was assessed by amplifying the corresponding
DNA regions using primers listed in Supplementary Table 2. PCR was carried out
in 50 µl total reaction volumes, each containing spores, 0.5 µM of each primer, 10 µl
of 5x HF buffer (Thermo Scientiﬁc, United States), 200 µM dNTPSs, 1 M Betaine,
and 0.5 µl of Phusion (Thermo Scientiﬁc, United States). The reaction mixture was
heated to 98 °C for 2 min, followed by 35 cycles, each consisting of 5 sec dena-
turation at 98 °C, 10 sec annealing at 61 °C, 1.5 min extension at 72 °C, and a ﬁnal
7 min extension at 72 °C. The sequence of each PCR fragment containing the
promoter was also conﬁrmed.
Microbial ketone production. Engineered Streptomyces spores (50 µl) were grown
in 3 ml of TSB containing nalidixic acid (25 mg · l−1) and apramycin (25 mg · l−1)
for 2–4 days at 30°. S. coelicolor, S albus, and S. aureofaciens grow more slowly than
S. venezuelae and usually took 3–4 days to have enough growth. 0.5 ml of overnight
culture was transferred to a 250 ml non-bafﬂed ﬂask containing 30 ml of 042
medium25, nalidixic acid (25 mg · l−1) and apramycin (25 mg · l−1) ﬁtted with a
silicon sponge cap (https://www.sigmaaldrich.com/catalog/product/sigma/c1046?
lang=en&region=US). The culture was grown for 5 days at 30 °C at 200 rpm on a
Kuhner ISG-1-W shaker (Kuhner, United States). Furthermore, 300 µl of super-
natant was collected from the culture, mixed with 300 µl of methanol, and then
incubated at 50 °C overnight (the tube was covered with paraﬁlm). The resulting
solution was cooled to 4 °C, centrifuged at 10000 × g for 2 min, and then ﬁltered
using an Amicon Ultra Centrifugal ﬁlter, 3 kDa Ultracel, 0.5 mL device at 10000 × g
for 10 min (EMD Millipore, United States). The ﬂow-through was analyzed by
liquid chromatography time-of-ﬂight mass spectrometry (LC-TOF).
The same experimental procedures were used to produce and extract ketones
from engineered S. albus strains grown in modiﬁed Medium 042 except that the
culture was grown for 9 days to fully consume sugars derived from plant biomass.
In a bioreactor, engineered S. albus spores were grown in 3 ml of TSB
containing nalidixic acid (25 mg · l−1) and apramycin (25 mg · l−1) for 2–4 days at
30 °C. Seed culture grown on TSB was used to inoculate the second seed with 50 ml
of Medium 042 (inoculum size was 8 Vol%). The second seed was grown in shake
ﬂasks for overnight at 30 °C. 20 ml of overnight culture was transferred to a 2 l
bioreactor containing 700 ml of 042 medium, nalidixic acid (25 mg · l−1) and
apramycin (25 mg · l−1). Fermentation conditions were controlled to achieve a
temperature of 30 °C, to maintain pH 7.2, and to dissolve oxygen at 40% of
dissolved oxygen saturation. Dissolved oxygen was controlled by setting up a
cascade on agitation and air ﬂow. The minimum and maximum cascade range for
agitation was 200 and 400 rpm respectively; for aeration the range was 0.5 and 1.0
LPM. The cascade controlled the dissolved oxygen by ﬁrst changing the agitation
speed and then air ﬂow rate. The pH was controlled at 7.2 by addition of 2M
NaOH. The foaming issue was controlled by addition of 5 Vol% of Antifoam 204.
Streptomyces cell growth measurement. Growth of Streptomyces cells was
measured using the Bradford assay. Upon harvest of shake ﬂasks 1 ml of the culture
was spun down at 10,000 × g for 5 min and supernatant was decanted. Cells were
then washed with deionized water once and resuspended in deionized water to ﬁnal
volume of 1 ml. Furthermore, 20 μl of washed cells were mixed with 1 ml of Quick
Start Bradford 1x Dye Reagent (BIO-RAD, United States) and absorbance of the
mixture was measured at 595 nm immediately at room temperature.
Ketone production analysis. LC separation of ketones was conducted on a
Kinetex XB-C18 reversed phase column (100 mm length, 2.1 mm internal dia-
meter, 2.6 μm particle size; Phenomenex, United States) using an Agilent 1200
Rapid Resolution LC system (Agilent Technologies, United States). The mobile
phase was composed of water (solvent A) and methanol (solvent B). Ketones were
each separated via the following gradient: increased from 35 to 90.4% B in 4.4 min,
held at 90.4% B for 2.2 min, decreased from 90.4 to 35% B in 0.2 min, and held at
35% B for an additional 2.7 min. The ﬂow rate was held at 0.18 ml · min−1 for 4.4
min, increased from 0.18 to 0.4 ml · min−1 in 0.2 min, and held at 0.4 ml · min−1
for an additional 4.9 min. The total LC run time was 9.5 min. The column com-
partment and autosampler temperatures were set to 50°C and 6°C, respectively.
Samples were injected into the LC column at a volume of 10 μl. The Agilent 1200
Rapid Resolution LC system was coupled to an Agilent 6210 TOF (Agilent
Technologies, United States). Nitrogen gas was used as both the nebulizing and
drying gas to facilitate the production of gas-phase ions. The drying and nebulizing
gases were set to 10 l · min−1 and 25 l · bin−2, respectively, and a drying gas tem-
perature of 325°C was used throughout. Atmospheric pressure chemical ionization
was conducted in the positive-ion mode with capillary and fragmentor voltages of
3.5 kV and 100 V, respectively. The skimmer, OCT1 RF, and corona needle were
set to 50 V, 170 V, and 4 µA, respectively. The vaporizer was set to 350°C. Ketones
were detected via [M+H]+ ions: m/z= 87.08044; m/z= 101.09609; m/z=
115.11174. The analysis was performed using an m/z range of 66 to 166. Data
acquisition and processing were performed using MassHunter software (Agilent
Technologies, United States). For 4-methyl-3-hexanone, because the authentic
standard is not commercially available, the isomer, 5-methyl-3-hexanone was used
to quantify the product.
Biomass pretreatment and sacchariﬁcation. A mixture containing 15% corn
stover biomass (7% w/w moisture), 1.5% NaOH, and 83.5% water was pretreated
by autoclaving at 121 °C for 1 h. Following pretreatment, the biomass was wrapped
in cheesecloth and dried in a laundry centrifuge to approximately 30% w/w solids.
The supernatant was discarded, and biomass was re-suspended and soaked in
deionized water overnight with pH adjusted to 5.0. The preparation was then
centrifuged a second time to remove excess salt and moisture. Pretreated biomass
was sacchariﬁed in 2-L LR-2.ST IKA reactors (IKA, United States) using com-
mercially available enzymes CTec2 and HTec2 (Novozymes, Denmark). Enzymes
with following loadings were added to the reactor: 64 mg CTec2 · g−1 dry biomass
and 8 mg HTec2 · g−1 dry biomass. Enzymatic sacchariﬁcation was performed at
50 °C with pH in the range of 4.5 to 5.5 for 96 h. Upon completion of the sac-
chariﬁcation reactions, the unhydrolyzed biomass was separated from the hydro-
lysate by centrifugation at 4000 × g for 30 min. The hydrolysate was ﬁltered with
0.7 μm and then 0.45 µm ﬁlter papers to separate any remaining particles and
ﬁnally sterilized by passing through 0.2-μm ﬁlters and stored at 4 °C for further use.
The ﬁnal hydrolysate contained 86.5 g · l−1 of free glucose and 38.1 g · l−1 of free
xylose.
Sugar consumption analysis. Glucose and xylose concentrations in the aqueous
portion of fermentation samples were quantiﬁed by high pressure liquid chro-
matography (HPLC). This method is suitable for detection and quantiﬁcation of
individual sugars. The apparatus used was Ultimate 3000 HPLC system® (Thermo
Scientiﬁc, United States) equipped with a Shodex Refractive Index® detector
(Shoko Scientiﬁc Co., Ltd., Japan). The carbohydrates were separated on an
Aminex HPX-87H (Bio-Rad, United States) column with 9 μm particle size and
300 mm × 7.8 mm dimensions. A standard cartridge holder was used to protect
the column. The mobile phase was 0.01 N sulfuric acid with a ﬂow rate of
0.6 ml · min−1, the oven temperature was 65 °C, and the analysis time was 30 min.
Integration and analysis of samples was performed using Dionex Chromeleon®
software (Thermo Scientiﬁc, United States). Identiﬁcation of monosaccharide
content was determined relative to known standards. Limits of detection for glu-
cose and xylose were .80 mg · l−1.
Octane number analysis. A special Reformulated Blendstock for Oxygenate
Blending formulae mandated by the state of California (CARBOB) was used as a
base gasoline. Each ketone (or alcohol) purchased from Sigma-Aldrich (United
States) or TCI (Japan) was blended at 10, 20, or 30 Vol% into 500 ml of CARBOB.
Research octane number and Motor octane number for ketone or alcohol-blended
gasolines were determined using ASTM methods D2699 and D2700, respectively,
by Intertek (United States).
Auto ignition temperature analysis. 2-Methyl-3-pentanone and 3-methyl-2-
butanone purchased from Sigma-Aldrich (United States) or TCI (Japan) were
analyzed using ASTM methods E659 by Alcor Petrolab (United States).
GC-FID analysis. After the decane or the dodecane layers were sampled, they were
analysed by GC-FID (Thermo Focus with FID) equipped with a DB-5 column (30
m, 0.32 mm ID, 0.5 μm ﬁlm), using a the corresponding standard curve using the
following conditions: inlet at 250 °C, FID at 250 °C, 50 kPa constant pressure; oven:
35 °C, 5 °Cmin−1 to 60 °C, 80 °C min−1 to 250 °C, and the hold for 5 min.
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Data availability
The DNA sequences of plasmids and strains used in this study have been deposited
in the public version of JBEI registry (http://public-registry.jbei.org). Please refer to
Supplementary Table 4 for accession codes.
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